These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

15 related articles for article (PubMed ID: 8459972)

  • 1. Comparison of pregnancy rates in antagonist cycles after luteal support with GnRH-agonist versus progesterone: prospective randomized study.
    Buhbut E; Nabulsi R; Avigdor G; Ben-Ami I
    Arch Gynecol Obstet; 2023 Jul; 308(1):255-263. PubMed ID: 37186265
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Follicular phase serum levels of luteinizing hormone do not influence delivery rates in in vitro fertilization cycles down-regulated with a gonadotropin-releasing hormone agonist and stimulated with recombinant follicle-stimulating hormone.
    Cabrera RA; Stadtmauer L; Mayer JF; Gibbons WE; Oehninger S
    Fertil Steril; 2005 Jan; 83(1):42-8. PubMed ID: 15652885
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perinatal outcome of pregnancies after inadvertent exposure to gonadotrophin-releasing hormone analogue.
    Tan HH; Yeong CT; Loh KE
    Aust N Z J Obstet Gynaecol; 2006 Aug; 46(4):336-40. PubMed ID: 16866796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Embryonic heart rate as a predictor of first-trimester pregnancy loss in infertility patients after in vitro fertilization.
    Rauch ER; Schattman GL; Christos PJ; Chicketano T; Rosenwaks Z
    Fertil Steril; 2009 Jun; 91(6):2451-4. PubMed ID: 18656184
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cyst formation following GnRH agonist administration in IVF cycles: incidence and impact.
    Qublan HS; Amarin Z; Tahat YA; Smadi AZ; Kilani M
    Hum Reprod; 2006 Mar; 21(3):640-4. PubMed ID: 16253965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short coasting of 1 or 2 days by withholding both gonadotropins and gonadotropin-releasing hormone agonist prevents ovarian hyperstimulation syndrome without compromising the outcome.
    Moon HS; Joo BS; Moon SE; Lee SK; Kim KS; Koo JS
    Fertil Steril; 2008 Dec; 90(6):2172-8. PubMed ID: 18439601
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GnRH agonist exposure during the first trimester of pregnancy.
    Young DC; Snabes MC; Poindexter AN
    Obstet Gynecol; 1993 Apr; 81(4):587-9. PubMed ID: 8459972
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 9.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 10.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 11.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 1.